| __timestamp | TG Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 24518692 | 91733000 |
| Thursday, January 1, 2015 | 19886580 | 87644000 |
| Friday, January 1, 2016 | 12631689 | 92365000 |
| Sunday, January 1, 2017 | 21977998 | 85656000 |
| Monday, January 1, 2018 | 20759000 | 88196000 |
| Tuesday, January 1, 2019 | 20838000 | 89971000 |
| Wednesday, January 1, 2020 | 121812000 | 93413000 |
| Friday, January 1, 2021 | 152137000 | 91355000 |
| Saturday, January 1, 2022 | 83231000 | 113676000 |
| Sunday, January 1, 2023 | 122706000 | 198366000 |
| Monday, January 1, 2024 | 218935000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, TG Therapeutics saw a dramatic increase in SG&A expenses, peaking in 2021 with a staggering 550% rise from 2016. Meanwhile, Taro Pharmaceuticals maintained a more stable trajectory, with expenses fluctuating modestly around the $90 million mark until a notable 75% increase in 2023. This divergence highlights TG Therapeutics' aggressive expansion strategy, while Taro's steady approach underscores its focus on operational efficiency. The data for 2024 is incomplete, leaving room for speculation on future trends. This financial insight offers a window into the strategic priorities of these two industry players.
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Bristol-Myers Squibb Company or Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Supernus Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.
Who Optimizes SG&A Costs Better? Amphastar Pharmaceuticals, Inc. or Taro Pharmaceutical Industries Ltd.